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ABSTRACT 
Objective: To explore the safety profile of the proposed polyherbal formulation LQ 14 which is composed of 
various antimicrobial ingredients in rodents according to OECD (423) for acute oral toxicity study and OECD 
(407) for 28-days repeated dose toxicity study. Materials and methods: Acute toxicity studies and 28-days 
repeated dose toxicity were done on male Swiss slbino mice and Wistar albino rats. The animals were 
randomly divided into four groups of five animals each (n=20). In acute toxicity study, three doses of the 
extract (2.5-10 ml/kg body weights) were administered to 3 groups of the animals respectively. All animals 
were observed for 24 hours and general symptoms of toxicity and mortality were recorded. In 28-days 
repeated dose toxicity study, wistar male rats were grouped by randomized design and assigned to three 
groups of 6 animals each (n=18). Two doses of the extract (2.5, 5 ml/kg body weight) were administered 
daily to 2 groups. The last group was control in both and received 10, 5 ml/kg body weight of deionized 
water. Route of administration was oral in all the groups of animals. Results: No treatment related toxicity 
was found in both acute and repeated dose toxicity studies. Conclusion: The absence of biologically 
significant differences in the toxicological endpoints supports the safety of LQ14 in the treatment of 
diarrhea. 
KEYWORDS: Diarrhoea, Polyherbal drug, Acute toxicity study, OECD guidelines, Toxicology, Endpoints. 
INTRODUCTION 
 Assurance of safety, quality and efficacy of 
medicinal plants and herbal products is a key issue, which 
needs to be addressed. Both the general consumer and 
health care professional need up-to-date authoritative 
information on the safety and efficacy of phyto-
medicines[1,2]. Further, conducting toxicity studies for 
herbal preparations is essential step that will strengthen 
the acceptance of herbal medicines by scientific 
community. The test drug, formulation LQ14 contained 
herbs and its parts of Holarrhena antidysenterica, 
Mangifera indica, Cyperus rotundus, Centella asiatica, 
Curcuma longa etc. and possess significant anti-viral, anti-
protozoal, bactericidal and anti-diarrhoeal properties. All 
the components in the test formulation LQ 14 have been 
reported in Indian Ayurvedic Pharmacopia (vide 
reference) and mentioned their use as medicine before 
1000 BC to present time. But as all these components are 
mixed in a new formulation by modern techniques 
(solvent extraction) hence, it is necessary to find out 
whether any adverse effect originated from this process of 
preparation of in combination. In that regards, it was 
considered to examine the toxicological investigations on 
LQ14.  
MATERIALS AND METHODS 
Test Formulation LQ14 
 The proprietary test formulation LQ14 was 
formulated, prepared and supplied in the liquid form in 
amber coloured bottle by the sponsor of the present 
research project. The anticipated therapeutic action is 
anti-diarhhoeal. The formulation contains five herbal parts 
and other constituents, like thickener, preservative, 
stabilizer, solvent etc.  
 The shelf-life of LQ14 is 36 months if it is 
preserved at 25±2ºC in dark cool bottle. The density of 
LQ14 is 1300 Kg/m3 and specific gravity is 1.3 when 
packed. The LQ14 was analyzed for heavy metals 
contamination and atomic absorption spectroscopic (AAS) 
reports informed that LQ14 contains 2.34 ppm lead, less 
than 0.05 ppm arsenic, less than 0.002 ppm cadmium and 
0.248 ppm mercury. 
Phytoconstituents information of the test formulation [3-9] 
Sl. No. Name of Ingredients Parts used Activities Amount (%) 
1. Kurchi (Holarrhena antidysenterica) Stem bark Antimicrobial 100 mg 
2. Mango (Mangifera indica) Leaves Antimicrobial 100 mg 
3. Musta (Cyperus rotundus) Rhizome Antimicrobial 20 mg 
4. Mandukaparni (Centella asiatica) Whole plant Antimicrobial 20 mg 
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5. Haridra (Curcuma longa) Rhizome Antimicrobial 10 mg 
6. Pectin       - Thickener  4 mg 
7. Sodium benzoate      - Preservative 6 mg 
8. Citric acid      - Stabilizer 3 mg 
9. Purified water       - Solvent   q.s. 
Test Drug Preparation 
 The supplied test drug, LQ14 was ready to use. No 
other solvent was mixed throughout the study.  
Reagents and Chemicals 
 The test drug was supplied by the sponsor (M/s 
Parker Robinson Pvt. Ltd., Kolkata). Castor oil (M/s Dabur 
India Limited, India), Charcoal (M/s Merck, India), 
Loperamide (Lopamide, M/s Torrent, India), Cell Diluting 
Fluids (M/s StanBio, India), Biological Commercial Kits 
(M/s Span Diagnostics Ltd, India) and other general 
reagents were used.  
Etihcs Clearance 
 The study began after obtaining ethics clearance 
from the Institutional Ethics Committee (IEC) no: PR-
HC/06 ETHICs/ 1019. The local body of CPCSEA and the 
IAEC were non-functioning, so IEC has provided the 
approval for this study. Some of the members of both IEC 
and IAEC were in common, hence approval was solely 
provided by the IEC. 
Animals and animal care 
 In accordance with the CPCSEA guidelines, 
animals were allowed to be acclimatized for a period of 2 
weeks in our laboratory environment prior to the study. 
Animals were housed in polypropylene cages (4 animals 
per cage), maintained under standard laboratory 
conditions (i.e. 12:12 hour light and dark sequence; at an 
ambient temperature of 25±2ºC; 35-60% humidity); the 
animals were fed with nutritionally balanced pellet diet for 
rodent and water ad libitum. 
Acute Toxicity Studies 
 LQ14 was tested for acute oral toxicity study 
following the guidelines of OECD (423) [3,4,5]. Swiss (IB) 
male albino mice (25 g) and Wistar/NIN(IB) albino rats 
(150 g) were randomly divided into three groups of five 
animals each. The age of rats and mice being 12 weeks. 
Male animals were chosen for safety evaluation as female 
animals possess fluctuations in their hormonal mileu 
resulting from estrus cycle. Female animals were not used 
as most of them were pregnant. The animals were fed on 
mice and rats pellets and water ad libitum. The animals 
were starved for 12 hours prior to testing. Three doses of 
the extract (2.5-10 ml/kg body weights) were 
administered by oral intubation to 3 groups of the animals 
respectively by step-up method. Actual dose administered 
are mentioned in table 1.  
 The volume of the extract administered to each 
animal in the test group was calculated based on the body 
weight. All animals were observed for 24 h (extended upto 
3 days) and general symptoms of toxicity and mortality 
were recorded. 
28-Days Repeated Toxicity Studies [6,7] 
 OECD guidelines for the testing of chemicals 
(synthetic or natural) are periodically reviewed in the light 
of scientific progress, changing assessment practices and 
animal welfare considerations.[10,11,12] The original 
guideline 407 repeated dose 28-days oral toxicity studies 
in rodents have been adopted that is generally used for 
testing of herbal medicines.[13] Healthy Wistar stain male 
rats have been acclimatized to laboratory conditions for at 
least 7 days and have not been subjected to previous 
experimental procedures, were used. They were grouped 
by randomized design and assigned to two groups of 6 
animals each as follows:  
Group I: Control: given 5 ml/kg deionized water  
Group II: Low dose: given 2.5 ml/kg LQ14  
Group III: High dose: given 5 ml/kg LQ14  
 The polyherbal test formulation was given by oral 
route, once per day continuously for 28 days. The animals 
were maintained properly throughout the treatment. After 
completion of the study, the hematological analysis was 
conducted from living animals and thereafter, all animals 
were sacrificed under deep anesthesia. Blood samples 
were collected and preserved for biochemical estimations. 
The organs were excised for organ weight and histological 
studies. Throughout the study period, the following 
observations and investigations were conducted.  
Food & Water Consumption: Monitoring by measuring 
the water in the containers was done at day 0 and on day 
28. Quantity of food consumed was also estimated by given 
a weighed quantity of pellet diet followed by weighing the 
amount left over diet in the cage at the end of the 24 hours.  
Body Weight: The body weights of the animals were 
recorded at the time allocation of animals to the different 
groups, and the end of the study using electronic digital 
weighing machine for animals’ weight (5g) in fasting 
conditions. The weight gaining was calculated by 
extracting the results of initial weight and final weight. 
Hematological Studies: The hemoglobin concentration 
was studied following to cyanomethaemoglobin method. 
The counts of red blood cells and white blood cells were 
also done using hemocytometer.  
Biochemical Studies: Blood samples were collected from 
rats and serum was separated by centrifuge. The following 
parameters ware analyzed spectrophotometrically using 
commercial kits.  
 Serum Cholesterol 
 Serum Alanine transaminase (ALT) 
 Serum Aspartate transaminase (AST)  
 Serum Alkaline Phosphatase (ALP)  
 Blood Urea Nitrogen (BUN) 
 Serum Creatinine 
Organ Weight: The animals were sacrificed and the vital 
organs i.e. heart, liver, kidney and spleen were excised, 
cleaned, dried and weighed in high precision electronic 
weighing machine. The mean values of absolute organs 
weight was represented as g wt. Finally, the relative organ 
weight ratio was determined.  
Histopathological Studies 
 Histopathological studies on liver, kidney and 
spleen were conducted to find out any toxicity on these 
 Int. J. Ayur. Pharma Research, 2016;4(3):45-52  
 IJAPR | March 2016 | Vol 4 | Issue 3   47 
vital drug regulatory organs. Photomicrographs of 
representative tissues were taken at various 
magnifications. 
Statistical Analysis 
 Mean and standard error values were determined 
for all the parameters and the results were expressed as 
Mean ± SEM. The data were analyzed employing paired t-
test and comparison between the groups using statistical 
software SPSS version 17 (SPSS Sciences, Chicago, USA).  
RESULTS 
 In the single oral dose toxicity study of LQ14, no 
treatment related toxic changes were observed at the 
highest dose (10 ml/kg). Hence, the dose levels i.e., 1/4th 
(2.5 ml/kg) and 1/2 (5 ml/kg) with a common ratio of 2 of 
the highest dose tested (10 ml/kg), were selected for 28 
days repeated dose study. All experiments were conducted 
following the guidance of Good Laboratory Practice (GLP) 
for experimental animals. The observations from this 
study are as follows:  
1. General Observation: All animals were examined 
twice daily for general appearance, behavior, and signs 
of toxicity, morbidity, and mortality. There was no 
mortality in the 28 days repeated dose oral toxicity 
testing (Table 1). All the animals of treated and control 
groups remained active and healthy during the period 
of the study.  
2. Food & Water Consumption: Monitoring of food and 
water consumption revealed irregular variations in the 
average 24 hour food and water intake of animals in the 
control and treated groups (Table 2). However, there 
was no variations with the test substance, LQ14.  
3. Body Weight: Animals in all groups gained weight and 
it remained fairly constant throughout the 
experimental period (Table 3, Fig. 1). However, no 
significant differences were observed among LQ14 
treatment groups as compared to the control group. 
4. Hematological Studies: The results of examination of 
hematological parameters of LQ14 treated and control 
group are shown in Table 4. No biologically significant 
differences in hematological profiles were observed. 
The hematological parameters were within normal 
limits.  
5. Biochemical Studies: Examination of the serum 
biochemistry values of the test compound, LQ14 
treated and control group is shown in Table 5. 
Biochemical parameters of liver function and renal 
function did not reveal hepatic or renal impairment 
following the administration of LQ14. 
6. Organ Weight: There were no marked differences in 
the weights of various vital organs (heart, liver, kidney, 
spleen) of the rats treated with LQ14 when compared 
to control (Table 6). Gross examination and even 
microscopic study of the vital organs on autopsy did not 
reveal any abnormalities.  
7. Histopathological Studies: In all groups of animals, 
histological architecture of the liver was found to be 
within normal limits. (Fig. 2-10). Hepatocytes 
examination did not particularly reveal any necrosis or 
steatosis. Portal areas were without any particularity 
and Kupffer’s cells were not modified. It has not also 
been observed any fibrosis. In most observed cases, it 
has been observed that the normal histological 
structure of the spleen was respected. Further, the 
histological structure of the glomerulus was respected 
in all the observed groups of kidneys and it has neither 
been observed membrane thinning nor hyperplasia of 
mesengial cells or deposits of immunoglobulins. These 
observations clearly indicated that the polyherbal test 
formulation no toxic or side effect on tissue 
morphology. 
Table 1: Acute oral toxicity of LQ14 in rodents 
Species/ 
Group 
Dose 
ml/kg 
Log dose Dead/Total N Dead% Corrected
% 
Probit 
Day 1 Day 2 Day 3 
Mice         
1 2.5 0.3979 0/6 0/6 0/6 0 4.16 3.267 
2 5 0.6989 0/6 0/6 0/6 0 4.16 3.267 
3 10 1.0000 0/6 0/6 0/6 0 4.16 3.267 
Rats         
4 2.5 0.3979 0/6 0/6 0/6 0 4.16 3.267 
5 5 0.6989 0/6 0/6 0/6 0 4.16 3.267 
6 10 1.0000 0/6 0/6 0/6 0 4.16 3.267 
Corrected formula for 0%= 100(0.25/n), when n was the number of animals in the group 
Table 2: Effect of LQ14 on food and water consumption in rats 
Group Control LQ14 treatment 
Dose  5 ml/kg 2.5 ml/kg 5 ml/kg 
Day 0 Day 28 Day 0 Day 28 Day 0 Day 28 Day 
Food consumption 
(g/day) 
20.5±0.67 36.1±0.89 22.5±0.87 35.5±2.01 19.5±0.78 35±0.49 
Water consumption 
(ml/day) 
14.5±0.80 20±0.44 12.5±0.92 19±0.62 14±0.72 20.5±1.56 
N=6 rat in each group; Treatment= once/day/p.o. for 28 days; Values are Mean±SEM; Data are compared 
statistically by Paired test using software spss version 17 with respective group of control and showed not 
significant (NS) 
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Figure 1: Effect of LQ14 on body weight in rats 
 
Table 3: Effect of LQ14 on body weight in rats 
Group Control LQ14 treatment 
Dose  5 ml/kg 2.5 ml/kg 5 ml/kg 
Day 0 Day 28 Day 0 Day 28 Day 0 Day 28 Day 
Body weight (g) 135±2.82 171.3±2.29 140.8±5.38 172.6±2.30 136.8±2.47 173.9±2.62 
N=6 rat in each group; Treatment= once/day/p.o. for 28 days; Values are Mean±SEM; Data are compared 
statistically by Paired test using software SPSS version 17 with respective group of control and showed not 
significant (NS). 
Table 4: Hematological values of rats treated with LQ14 for 28 days 
Group Control LQ14 treatment 
Dose 5 ml/kg 2.5 ml/kg 5 ml/kg 
Hb (g%) 14.51±0.14 14.59±0.19 14.57±0.11 
RBC (106/mm3) 7.90±0.032 7.88±0.028 7.83±0.035 
WBC (103/mm3) 6.77±0.039 6.81±0.047 6.82±0.057 
Neutrophil (%) 45±1.38 43.8±1.16 44.5±1.11 
Eosinophil (%) 3.51±0.48 3.38±0.52 3.28±0.57 
Lymphocyte (%) 51±2.59 52±1.43 49.8±1.82 
Monocyte (%) 2.50±0.22 2.35±0.38 2.51±0.26 
N=6 rat in each group; Treatment= once/day/p.o. for 28 days; Values are Mean±SEM; Data are compared 
statistically by Paired test using software SPSS version 17 with respective group of control and showed not 
significant (NS). 
Table 5: Serum values of rats treated with LQ14 for 28 days 
Group Control LQ14 treatment 
Dose 5 ml/kg 2.5 ml/kg 5 ml/kg 
Cholesterol (mg/dl) 82.1±2.92 79.3±3.98 77.8±4.58 
ALT (IU/L) 34.6±0.95 31.8±1.83 34.7±1.45 
AST (IU/L) 36.7±1.45 33.2±1.72 34.9±1.40 
Alkaline Phosphatase (KA) 58.85±3.17 55.70±1.98 51.37±3.08 
BUN (mg/dl) 8.71±0.42 8.32±0.74 8.63±0.39 
Creatinine (mg/dl) 0.63±0.03 0.57±0.02 0.58±0.04 
N=6 rat in each group; Treatment= once/day/p.o. for 28 days; Values are Mean±SEM; Data are compared 
statistically by Paired test using software SPSS version 17 with respective group of control and showed not 
significant (NS) 
Table 6: Absolute organ weight of rats treated with LQ14 
Group Control LQ14 treatment 
Dose 5 ml/kg 2.5 ml/kg 5 ml/kg 
Heart (g) 0.459±0.008 0.455±0.007 0.458±0.006 
Liver (g) 5.29±0.118 5.37±0.109 5.45±0.127 
Kidneys (g) 0.558±0.006 0.551±0.007 0.549±0.008 
Spleen (g) 0.452±0.005 0.446±0.004 0.446±0.008 
N=6 rat in each group; Treatment= once/day/p.o. for 28 days; Values are Mean±SEM; Data are compared 
statistically by Paired test using software SPSS version 17 with respective group of control and showed not 
significant (NS) 
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Histopatological Findings of LQ14 treatment in the test group of rodents 
 
  a                   b                         c                      d 
 
Fig. 2: Normal Liver 
HE Stain 
a. Central Vein 
b. RBCs in sinusoids 
 c. Sinusoids 
d. Cords of hepatocytes 
 
 
Fig. 3: LQ14 - 2.5 ml/kg induced Liver 
 
Fig. 4: LQ14 - 5 ml/kg induced Liver 
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Fig 5: Normal Kidney 
HE Stain 
a. Glomuruli 
b. Blood vessels 
c. Lumen of kidney tubule 
d. Proximal and distal convulated 
tubule 
 
Fig. 7: LQ14 – 2.5 ml/kg induced Kidney 
 
Fig 6 : LQ14 – 5 ml/kg induced Kidney 
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Fig. 8: Normal spleen 
HE Stain 
a. Trabuculae  
b. Capsule  
c. Central arteriole 
d. White pulp 
e. Red pulp 
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Fig. 9: LQ14 – 2.5 ml/kg induced Spleen 
 
Fig. 10: LQ14 – 5 ml/kg induced Spleen 
DISCUSSION 
 The polyherbal test formulation LQ 14 has been 
prepared with the medicinal herbs like Holarrhena 
antidysenterica, Mangifera indica, Cyperus rotundus, 
Centella asiatica, Curcuma longa etc. All these components 
are well reported for anti-diarrhoeal and anti-microbial 
activities and used in the Indian subcontinent. [13-15] But, in 
combination (LQ14), it has not been used earlier. The test 
formulation in this study did not reveal any signs of 
toxicity or mortality up to 10 ml/kg per oral dose in mice 
and rats. The percentages of dead were corrected and the 
probit values were also determined but LD 50 could not be 
determined. The dose up to 10 ml/kg orally (extract) in 
mice and rat is safe and practically non-toxic. Further, 
behavioral observations related to sign of toxicity (activity, 
tremors, writhing, sedation, ptosis, lacrimation, diarrhoea 
etc.) were not noted in any animal of both the species up to 
10 ml/kg per oral dose. In this study, 4 weeks repeated 
oral dose of LQ14 obtained no evidence of adverse health 
effects in rats. During the course of investigation, no 
significant biological differences were observed in terms of 
body weight, food and water consumption and its 
efficiency among tested rats. In addition, clinical 
observations, behavioral assessment, and organ weights 
were not changed in all LQ14 treatment groups. No 
significant biological differences in hematological profiles, 
biochemical parameters and histological microscopic 
findings were observed. The absence of biologically 
significant differences in these toxicological endpoints 
supports the safety of LQ14 usage. All these findings 
collectively indicate that does not exert toxic effects in rats 
up to a concentration of 5 ml/kg/day upon 4 weeks 
repeated oral administration. 
CONCLUSION 
 The herbal test product, LQ14 could be assumed 
to have no lethal effects and is safe for oral use. The 
absence of biologically significant differences in these 
toxicological endpoints supports the safety of LQ14 usage 
in patients of acute diarrhoea. 
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